Entrada Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $331k | 32k | 10.28 |
| 2025-09-30 | $125k | 22k | 5.80 |
| 2025-06-30 | $122k | 18k | 6.72 |
| 2025-03-31 | $134k | 15k | 9.04 |
| 2024-12-31 | $255k | 15k | 17.29 |
| 2024-09-30 | $182k | 11k | 15.98 |
| 2024-06-30 | $155k | 11k | 14.25 |
| 2024-03-31 | $108k | 7.6k | 14.18 |
| 2023-12-31 | $100k | 6.6k | 15.10 |
| 2023-09-30 | $84k | 5.3k | 15.80 |
| 2023-06-30 | $124k | 8.2k | 15.14 |
| 2022-12-31 | $2.3k | 168 | 13.52 |
| 2022-09-30 | $2.9k | 165 | 17.39 |
| 2022-06-30 | $2.3k | 113 | 20.00 |
| 2022-03-31 | $21k | 2.3k | 9.19 |
| 2021-12-31 | $91k | 5.3k | 17.11 |